Endocannabinoids: a new class of vasoactive substances (Q41742759)

8 October 2017

1 reference

title

Endocannabinoids: a new class of vasoactive substances (English)

1 reference

8 October 2017

0 references

M D Randall

1

1 reference

PubMed ID

9550942

8 October 2017

D A Kendall

series ordinal

2

1 reference

8 October 2017

1 February 1998

1 reference

Trends in Pharmacological Sciences

8 October 2017

1 reference

8 October 2017

19

1 reference

8 October 2017

2

1 reference

8 October 2017

55-58

1 reference

A novel probe for the cannabinoid receptor

8 October 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901161-9

7 January 2021

Isolation and structure of a brain constituent that binds to the cannabinoid receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901161-9

7 January 2021

Two new unsaturated fatty acid ethanolamides in brain that bind to the cannabinoid receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901161-9

7 January 2021

Head group analogs of arachidonylethanolamide, the endogenous cannabinoid ligand

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901161-9

7 January 2021

The peripheral cannabinoid receptor: adenylate cyclase inhibition and G protein coupling

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901161-9

7 January 2021

Mast cells express a peripheral cannabinoid receptor with differential sensitivity to anandamide and palmitoylethanolamide

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901161-9

7 January 2021

Enzymatic synthesis and degradation of anandamide, a cannabinoid receptor agonist

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901161-9

7 January 2021

Enzymatic synthesis of anandamide, an endogenous ligand for the cannabinoid receptor, by brain membranes

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901161-9

7 January 2021

Partial purification and characterization of the porcine brain enzyme hydrolyzing and synthesizing anandamide

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901161-9

7 January 2021

Biosynthesis of an endogenous cannabinoid precursor in neurons and its control by calcium and cAMP.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901161-9

7 January 2021

Occurrence and biosynthesis of endogenous cannabinoid precursor, N-arachidonoyl phosphatidylethanolamine, in rat brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901161-9

7 January 2021

Formation and inactivation of endogenous cannabinoid anandamide in central neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901161-9

7 January 2021

Anandamide amidohydrolase activity in rat brain microsomes. Identification and partial characterization

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901161-9

7 January 2021

Inhibition of anandamide hydrolysis in rat brain tissue by (E)-6-(bromomethylene) tetrahydro-3-(1-naphthalenyl)-2H-pyran-2-one.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901161-9

7 January 2021

Novel antagonist implicates the CB1 cannabinoid receptor in the hypotensive action of anandamide

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901161-9

7 January 2021

Cardiovascular effects of anandamide in anesthetized and conscious normotensive and hypertensive rats

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901161-9

7 January 2021

Physiological and behavioural effects of the endogenous cannabinoid, arachidonylethanolamide (anandamide), in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901161-9

7 January 2021

Potentiation of anandamide hypotension by the transport inhibitor, AM404

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901161-9

7 January 2021

Cardiovascular effects of (-)-11-OH-delta 8-tetrahydrocannabinol-dimethylheptyl in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901161-9

7 January 2021

An endogenous cannabinoid as an endothelium-derived vasorelaxant

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901161-9

7 January 2021

Comparative pharmacology of endothelium-derived hyperpolarizing factor and anandamide in rat isolated mesentery

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901161-9

7 January 2021

Involvement of a cannabinoid in endothelium-derived hyperpolarizing factor-mediated coronary vasorelaxation

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901161-9

7 January 2021

Production and physiological actions of anandamide in the vasculature of the rat kidney.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901161-9

7 January 2021

Evidence that anandamide and EDHF act via different mechanisms in rat isolated mesenteric arteries.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901161-9

7 January 2021

A comparison of EDHF-mediated and anandamide-induced relaxations in the rat isolated mesenteric artery.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901161-9

7 January 2021

Endothelium-derived hyperpolarizing factor: a new endogenous inhibitor from the vascular endothelium

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901161-9

7 January 2021

Endothelium-dependent hyperpolarization: a role in the control of vascular tone

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901161-9

7 January 2021

Endothelium-dependent hyperpolarization. Beyond nitric oxide and cyclic GMP.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901161-9

7 January 2021

Characterization and modulation of EDHF-mediated relaxations in the rat isolated superior mesenteric arterial bed.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901161-9

7 January 2021

SR141716A, a potent and selective antagonist of the brain cannabinoid receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901161-9

7 January 2021

Display of the characteristics of endothelium-derived hyperpolarizing factor by a cytochrome P450-derived arachidonic acid metabolite in the coronary microcirculation

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901161-9

7 January 2021

Identification of epoxyeicosatrienoic acids as endothelium-derived hyperpolarizing factors

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901161-9

7 January 2021

Effects of cytochrome P450 inhibitors on EDHF-mediated relaxation in the rat hepatic artery.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901161-9

7 January 2021

Involvement of voltage-dependent potassium channels in the EDHF-mediated relaxation of rat hepatic artery

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2897%2901161-9

7 January 2021

10.1016/S0165-6147(97)01161-9

Identifiers

DOI

1 reference

8 October 2017

1 reference

PubMed ID

9550942